• Login
    View Item 
    •   NWU-IR Home
    • Electronic Theses and Dissertations (ETDs)
    • Health Sciences
    • View Item
    •   NWU-IR Home
    • Electronic Theses and Dissertations (ETDs)
    • Health Sciences
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    A behavioural investigation into the potential antidepressant-like properties of trimetazidine in an animal model of depression

    Thumbnail
    View/Open
    Engelbrecht_BJ.pdf (2.592Mb)
    Date
    2021
    Author
    Engelbrecht, B.J.
    Metadata
    Show full item record
    Abstract
    Major depressive disorder (MDD) is a neuropsychological disorder that affects up to 20 % of adolescents. Current first-line treatment strategies are, at best, effective in only 65 % of depressed patients, and are limited to the selective serotonin reuptake inhibitors (SSRIs), fluoxetine and escitalopram. Moreover, the prevalence of MDD¹ across various population groups remains and highlights the need for novel treatment strategies. To this end, mitochondrial function can provide novel insights into the pathophysiology of MDD. Evidence points to mitochondrial dysfunction in several conditions, including neuropsychiatric disorders such as Alzheimer’s disease, Parkinson’s disease, Down Syndrome and MDD. Trimetazidine (TMZ) has been shown to elicit mitochondrial enhancing properties (e.g., increase the adenosine triphosphate (ATP) concentration in the myocardium) and has been effectively used in the treatment of stable angina. Furthermore, recent studies have shown TMZ² to possess antipsychotic -and anxiolytic-like properties. In this work, we aimed to investigate the potential role of mitochondrial dysfunction in a validated animal model of MDD, i.e., the FSL rat, by assessing the possible antidepressant-like effects of the mitochondrial enhancer, TMZ. Laboratory housed male Flinders sensitive line (FSL) and Flinders resistant line (FRL) rats were used in our work. The FSL³ model is validated as a model of depression by presenting with good face, predictive and construct validity. Briefly, adolescent male FRL⁴ and FSL rats were randomly and equally (n = 12) divided into control groups that received tap water (control). FSL rats were further randomly allocated and divided into either escitalopram (ESC) (20 mg/kg/day) (n = 9), TMZ 10 mg/kg/day (n = 12) or 20 mg/kg/day (n = 13) and 2,4-dinitrophenol (DNP) (30 mg/kg/day) (n = 12), a pharmacological control for TMZ, treatment groups with treatment administered via drinking water for 28-days, starting on postnatal (PND) day 40. DNP acts as a mitochondrial uncoupler, effectively decreasing the amount of ATP produced that was used to compare to the behavioural effects TMZ, which according to literature, can increase ATP levels. On PND⁵ 60 animals were subjected to the first sucrose preference test (SPT), to measure anhedonia, followed by consecutive open field tests (OFT), to assess general anxiety-like behaviour and locomotor activity to better interpret other mobile-related behaviour on PND 66 and 67. The forced swim test (FST) was performed on PND 67, after the second OFT⁶, to identify depressive-like behaviour. The elevated plus maze (EPM) was performed 24 h later, on PND 68, to assess the anxiety-like behaviour of the animals. Finally, the SPT¹ was reintroduced on PND 69, followed by euthanasia via decapitation on PND 70.
    URI
    https://orcid.org/0000-0002-5741-6926
    http://hdl.handle.net/10394/38445
    Collections
    • Health Sciences [1850]

    Copyright © North-West University
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of NWU-IR Communities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisor/SupervisorThesis TypeThis CollectionBy Issue DateAuthorsTitlesSubjectsAdvisor/SupervisorThesis Type

    My Account

    LoginRegister

    Copyright © North-West University
    Contact Us | Send Feedback
    Theme by 
    Atmire NV